Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics announced a voluntary disclosure regarding the official publication of its ‘Samsung Biologics ESG Report 2024’, which highlights its economic, environmental, and social performance for 2023 alongside three-year non-financial trends.
📊 [Key Disclosure Details & Summary Statistics]
- Report Title: Samsung Biologics ESG Report 2024
- Assurance Agency: BSI (British Standards Institution) Group Korea
- Reporting Standards & Assurance Framework:
- Reporting Framework: In accordance with GRI Standards 2021; referenced ISO 26000, UN Global Compact principles, Framework, SASB, ESRS, ISSB, and TCFD recommendations
- Assurance Standard: Verified under AA1000AS v3 (2020) and meets the 4 principles of AA1000AP (2018)
- Access Location: Samsung Biologics official website (https://samsungbiologics.com/kr/esg/resources)
- Submission (Verification) Date: May 30, 2024
- Report Scope & Structure:
- Coverage Period: January 1, 2023 – December 31, 2023 (Includes select achievements up to the 2024 publication date; quantitative data covers 2021–2023 trends)
- Report Contents:
- Ⅰ. Management Report: Letter to Stakeholders, company overview, business progress, and growth & innovation
- Ⅱ. ESG Report: ESG governance & strategy, double materiality assessment, Governance, Environmental, and Social performance
- Ⅲ. ESG Fact Book: Financial/non-financial figures, GRI/TCFD/TNFD/SASB index tables, greenhouse gas verification report, and ESG policies
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Reviewing Published ESG Metrics and Corporate Policy Disclosures
This voluntary disclosure informs the market of the publication of the company’s annual ESG performance and non-financial management report. Accessing the published report via the provided website link to verify detailed non-financial metrics—such as greenhouse gas emissions and governance compliance—is important for understanding the company’s sustainability management framework and non-financial risk management. Relevant details can be confirmed through the official website or upcoming periodic reports.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided strictly for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
